Israel Active

Albert Bourla, CEO of Pfizer explains why he chose Israel as the priority destination for his company’s SARS-COV-2 vaccine.  A small population, a good healthcare system, a high degree of electronic data and an obsessive Prime Minister. And the scientific partnership has a great future.

Israel’s five millionth recipient of the Covid-19 vaccine was a pregnant 34-year-old from the Tel Aviv suburb of Petah Tikva, Restaurants, cafes, attractions, hotels, event venues, places of worship, most school grades 7-10, and more, have opened. Only 3% of serious Covid-19 cases had received a 2nd shot.

Hebrew University researchers have developed a chip containing human tissue with microscopic sensors to precisely monitor the response of the kidney, liver and heart to specific treatments. It is believed to be the first treatment to be submitted to the US FDA for human trials without animal testing.

Tel Aviv University Professor Neta Erez made the unusual offer on Reddit.com to answer any questions in one day, about her specialty of cancer research. She answered 61 tough questions.

Four women from Israel’s diverse, inclusive society enthusiastically speak about their life-saving work as volunteer paramedics with Israeli emergency service United Hatzalah.

Some 600,000 hysterectomies are performed annually in the US. The US FDA has just approved the Hominis Surgical System, developed by Israel’s Memic. The surgeon operates using the Robotically Assisted Surgical Device (RASD) via tiny incisions in the patient’s body.

Israeli startup ForSight Robotics is developing a microsurgical robotic platform for eye surgery. The platform will exceed human surgical capabilities with unprecedented dexterity and maneuverability to within only a few microns.

Israel’s Belkin Laser (reported previously) is conducting a large-scale clinical study of its Eagle laser glaucoma treatment in Europe and Israel. Patients at more than 10 sites are testing the computer-guided device that uses healing lasers far less intrusively than currently approved devices.

Scientists at Ben Gurion University have confirmed the diagnosis of Alzheimer’s disease, epilepsy, traumatic brain injury and stroke from electroencephalogram (EEG) patterns. Analysis of changes in brain blood vessel pathology can provide fast diagnosis of those conditions.

Arab-Israeli Professor Ashraf Brik (see previously) of Israel’s Technion and his team have overcome a 60-year technical problem to synthesize plectasin, a peptide with promising antibiotic results against multi-resistant bacteria, and linaclotide, to treat irritable bowel syndrome.